Download PDF
Semin Neurol 2002; 22(1): 089-094
DOI: 10.1055/s-2002-33051
HISTORICAL NOTE

Copyright © 2002 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Absinthe: Return of the Green Fairy

Christopher P. Holstege1 , Michael R. Baylor2 , Daniel E. Rusyniak3
  • 1Division of Medical Toxicology, Department of Emergency Medicine, University of Virginia, Charlottesville, Virginia
  • 2Martha Jefferson Hospital, Charlottesville, Virginia
  • 3Department of Emergency Medicine, Division of Medical Toxicology, Indiana University School of Medicine, Indianapolis, Indiana
Further Information

Publication History

Publication Date:
12 August 2002 (online)

    Permissions and Reprints

ABSTRACT

Among the most popular and intriguing intoxicants of the Victorian Age, absinthe had all but disappeared after it was banned in nearly all developed countries in the early 1900s. A number of great artists and writers from the late 1800s used absinthe as a social drink, including Vincent van Gogh and Toulouse-Lautrec. A recent resurgence of absinthe use has occurred in Europe and is rapidly spreading to the United States. Despite its increasing popularity limited information exists on the mechanism of action and neurotoxicity of absinthe. This paper reviews some of the historical aspects of absinthe and aims to shed light on the mechanism of action and neurotoxicology of this the Green Fairy.

KEYWORDS

Absinthe - thujone - van Gogh - neurotoxicology - history of medicine

REFERENCES

  • 1 Arnold W N. Absinthe.  Sci Am . 1989;  260 112-117
    PubMedGoogle Scholar
  • 2 Anonymous. Lancet .  1906;  1531
    PubMedGoogle Scholar
  • 3 Vogt D, Montagne M. Absinthe: behind the emerald mask.  Int J Addict . 1982;  17 1015-1029
    PubMedGoogle Scholar
  • 4 Shaw W. Little green men. Details. August, 1999: 60-62
    Google Scholar
  • 5 Coughlin T. I drank with the devil. Maxim. October 1998 : 74-77
    Google Scholar
  • 6 Hemphill R E. The illness of Vincent Van Gogh.  Proc R Soc Med . 1961;  54 1083-1088
    PubMedGoogle Scholar
  • 7 Arnold W. Vincent van Goh and thujone connection.  JAMA . 1988;  260 3042-3044
    CrossrefPubMedGoogle Scholar
  • 8 Albert-Puleo M. Van Gogh's vision: thujone intoxication.  JAMA . 1981;  246 42
    CrossrefPubMedGoogle Scholar
  • 9 Del Castillo J, Anderson M. Marijuana, absinthe and the central nervous system.  Nature . 1975;  253 365-366
    PubMedGoogle Scholar
  • 10 Meschler J, Howlett A. Thujone exhibits low affinity for cannabinoid receptors but fails to evoke cannabimimetic responses.  Pharmaco Biochem Behav . 1999;  62 473-480
    PubMedGoogle Scholar
  • 11 Hold K, Sirisoma N, Ikeda T. Alpha-thujone (the active component of absinthe): gamma-aminobutyric acid type A receptor modulation and metabolic detoxification.  Proc Natl Acad Sci USA . 2000;  97 3826-3831
    PubMedGoogle Scholar
  • 12 Bonkovsky H, Cable E, Cable J. Porphyrogenic properties of the terpenes camphor, pinene, and thujone.  Biochem Pharmac . 1992;  43 2359-2368
    PubMedGoogle Scholar
  • 13 Strang J, Arnold W N, Peters T. Absinthe: what's your poison?.  <~>Though absinthe is intriguing, it is alcohol in general we should worry about. BMJ . 1999;  319 1590-1592
    PubMedGoogle Scholar
  • 14 Anonymous. Absinthe and alcohol.  Lancet . 1869;  1 334
    PubMedGoogle Scholar
  • 15 Weisbord S, Soule J, Kimmel P. Poison on line: acute renal failure caused by oil of wormwood purchased through the internet.  N Engl J Med . 1997;  337 825-827
    CrossrefPubMedGoogle Scholar
      >